LATEST MANUSCRIPTS IN Immunological Medicine
- Kunihiko Moriya, Kanako Mitsui-Sekinaka, Yujin Sekinaka, Akifumi Endo, Hirokazu Kanegane, Tomohiro Morio, Kohsuke Imai, Shigeaki Nonoyama. Clinical practice guideline for activated phosphatidyl inositol 3-kinase-delta syndrome in Japan. Immunological medicine. 2023, 46 (4): 153-157
Cited : 1Read More - Fatemeh Izadfar, Saba Belyani, Masomeh Pormohammadi, Simin Alizadeh, Mehrara Hashempor, Elaheh Emadi, Zohreh Sadat Sangsefidi, Mohammad Reza Jalilvand, Shima Abdollahi, Omid Toupchian. The effects of grapes and their products on immune system: a review. Immunological medicine. 2023, 46 (4): 158-162Cited : 0Read More
- Amrit Venkatesan, Usha Chouhan, Sunil Kumar Suryawanshi, Jyoti Kant Choudhari. An approach for prediction of B cell and T cell epitope candidates against Chikungunya virus. Immunological medicine. 2023, 46 (4): 163-174Cited : 0Read More
- Faegheh Ebrahimi Chaharom, Ali Asghar Ebrahimi, Faroogh Feghhi Koochebagh, Zohreh Babalou, Morteza Ghojazadeh, Leili Aghebati Maleki, Nader D Nader. Association of IL-17 serum levels with clinical findings and systemic lupus erythematosus disease activity index. Immunological medicine. 2023, 46 (4): 175-181Cited : 2Read More
- Risa Shindo, Ryohei Abe, Kenji Oku, Tomoki Tanaka, Yu Matsueda, Tatsuhiko Wada, Yoshiyuki Arinuma, Sumiaki Tanaka, Tatsuyoshi Ikenoue, Yoshitaka Miyakawa, Kunihiro Yamaoka. Involvement of the complement system in immune thrombocytopenia: review of the literature. Immunological medicine. 2023, 46 (4): 182-190Cited : 3Read More
- Hirotoshi Kato, Masafumi Suzuki, Kazuo Misumi, Hitoshi Kohsaka. Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis. Immunological medicine. 2023, 46 (4): 191-195Cited : 4Read More
- Hideto Kameda. JAK inhibitors ∼ overview∼. Immunological medicine. 2023, 46 (3): 108-111Cited : 1Read More
- Toshiaki Kogame, Gyohei Egawa, Kenji Kabashima. Exploring the role of Janus kinase (JAK) in atopic dermatitis: a review of molecular mechanisms and therapeutic strategies. Immunological medicine. 2023, 46 (3): 112-120Cited : 4Read More
- Hiroshi Nakase. Understanding the efficacy of individual Janus kinase inhibitors in the treatment of ulcerative colitis for future positioning in inflammatory bowel disease treatment. Immunological medicine. 2023, 46 (3): 121-130Cited : 2Read More
- Keita Kirito. Recent progress of JAK inhibitors for hematological disorders. Immunological medicine. 2023, 46 (3): 131-142Cited : 8Read More
- Kunihiro Yamaoka, Kenji Oku. JAK inhibitors in rheumatology. Immunological medicine. 2023, 46 (3): 143-152Cited : 7Read More
- Sayaka Shibata. Epigenetic control of skin immunity. Immunological medicine. 2023, 46 (2): 62-68Cited : 0Read More
- Nasrin Hassani, Arash Salmaninejad, Saeed Aslani, Eskandar Kamali-Sarvestani, Mahmood Vessal. The association between PD-1 gene polymorphisms and susceptibility to multiple sclerosis. Immunological medicine. 2023, 46 (2): 69-76Cited : 5Read More
- Yusei Miyazaki, Ken Sakushima, Masaaki Niino, Eri Takahashi, Kei Oiwa, Ryoji Naganuma, Itaru Amino, Sachiko Akimoto, Naoya Minami, Ichiro Yabe, Seiji Kikuchi. Smoking and younger age at onset in anti-acetylcholine receptor antibody-positive myasthenia gravis. Immunological medicine. 2023, 46 (2): 77-83Cited : 0Read More
- Ryu Watanabe, Kosaku Murakami, Toshimitsu Fujisaki, Hiromu Ito, Koichi Murata, Wataru Yamamoto, Takayuki Fujii, Hideo Onizawa, Akira Onishi, Masao Tanaka, Akio Morinobu, Motomu Hashimoto. Baseline erythrocyte sedimentation rate level predicts long-term inhibition of radiographic progression by tocilizumab: the KURAMA cohort. Immunological medicine. 2023, 46 (2): 84-92Cited : 1Read More
